These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Systematic review of protein biomarkers of invasive behavior in glioblastoma. Sayegh ET; Kaur G; Bloch O; Parsa AT Mol Neurobiol; 2014 Jun; 49(3):1212-44. PubMed ID: 24271659 [TBL] [Abstract][Full Text] [Related]
6. Identification of prognostic biomarkers for glioblastomas using protein expression profiling. Jung Y; Joo KM; Seong DH; Choi YL; Kong DS; Kim Y; Kim MH; Jin J; Suh YL; Seol HJ; Shin CS; Lee JI; Kim JH; Song SY; Nam DH Int J Oncol; 2012 Apr; 40(4):1122-32. PubMed ID: 22179774 [TBL] [Abstract][Full Text] [Related]
7. Biomarkers and therapeutic advances in glioblastoma multiforme. Sasmita AO; Wong YP; Ling APK Asia Pac J Clin Oncol; 2018 Feb; 14(1):40-51. PubMed ID: 28840962 [TBL] [Abstract][Full Text] [Related]
8. Systems Biology Approaches to Decipher the Underlying Molecular Mechanisms of Glioblastoma Multiforme. Kaynar A; Altay O; Li X; Zhang C; Turkez H; Uhlén M; Shoaie S; Mardinoglu A Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948010 [TBL] [Abstract][Full Text] [Related]
9. The presence of stem cell marker-expressing cells is not prognostically significant in glioblastomas. Kim KJ; Lee KH; Kim HS; Moon KS; Jung TY; Jung S; Lee MC Neuropathology; 2011 Oct; 31(5):494-502. PubMed ID: 21269333 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic and prognostic value of glycosyltransferase mRNA in glioblastoma multiforme patients. Oblinger JL; Pearl DK; Boardman CL; Saqr H; Prior TW; Scheithauer BW; Jenkins RB; Burger PC; Yates AJ Neuropathol Appl Neurobiol; 2006 Aug; 32(4):410-8. PubMed ID: 16866986 [TBL] [Abstract][Full Text] [Related]
11. Towards developing biomarkers for glioblastoma multiforme: a proteomics view. Jayaram S; Gupta MK; Polisetty RV; Cho WC; Sirdeshmukh R Expert Rev Proteomics; 2014 Oct; 11(5):621-39. PubMed ID: 25115191 [TBL] [Abstract][Full Text] [Related]
12. Glioblastoma biomarkers from bench to bedside: advances and challenges. Farias-Eisner G; Bank AM; Hwang BY; Appelboom G; Piazza MA; Bruce SS; Sander Connolly E Br J Neurosurg; 2012 Apr; 26(2):189-94. PubMed ID: 22176646 [TBL] [Abstract][Full Text] [Related]
18. Novel glioblastoma markers with diagnostic and prognostic value identified through transcriptome analysis. Reddy SP; Britto R; Vinnakota K; Aparna H; Sreepathi HK; Thota B; Kumari A; Shilpa BM; Vrinda M; Umesh S; Samuel C; Shetty M; Tandon A; Pandey P; Hegde S; Hegde AS; Balasubramaniam A; Chandramouli BA; Santosh V; Kondaiah P; Somasundaram K; Rao MR Clin Cancer Res; 2008 May; 14(10):2978-87. PubMed ID: 18483363 [TBL] [Abstract][Full Text] [Related]
19. Identification of diagnostic serum protein profiles of glioblastoma patients. Elstner A; Stockhammer F; Nguyen-Dobinsky TN; Nguyen QL; Pilgermann I; Gill A; Guhr A; Zhang T; von Eckardstein K; Picht T; Veelken J; Martuza RL; von Deimling A; Kurtz A J Neurooncol; 2011 Mar; 102(1):71-80. PubMed ID: 20617365 [TBL] [Abstract][Full Text] [Related]
20. Pathologic diagnosis of recurrent glioblastoma: morphologic, immunohistochemical, and molecular analysis of 20 paired cases. Kim JH; Bae Kim Y; Han JH; Cho KG; Kim SH; Sheen SS; Lee HW; Jeong SY; Kim BY; Lee KB Am J Surg Pathol; 2012 Apr; 36(4):620-8. PubMed ID: 22441548 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]